These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6272362)

  • 1. [[Dopamine receptor; characterization of D-2 receptor in the intermediate lobe of the pituitary gland (author's transl)].
    Munemura M
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1600-8. PubMed ID: 6272362
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and physiological studies of the beta-adrenoceptor and the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland: a review.
    Cote TE; Eskay RL; Frey EA; Grewe CW; Munemura M; Stoof JC; Tsuruta K; Kebabian JW
    Neuroendocrinology; 1982; 35(3):217-24. PubMed ID: 6290925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dopamine receptor in the intermediate lobe of the rat pituitary gland is negatively coupled to adenylate cyclase.
    Meunier H; Labrie F
    Life Sci; 1982 Mar; 30(11):963-8. PubMed ID: 6122149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland is associated with an inhibitory guanyl nucleotide component.
    Cote TE; Frey EA; Grewe CW; Kebabian JW
    J Neural Transm Suppl; 1983; 18():139-47. PubMed ID: 6308147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activity of the pars intermedia of the autotransplanted pituitary gland in the European eel].
    Olivereau M
    Z Zellforsch Mikrosk Anat; 1969; 98(1):74-87. PubMed ID: 5807449
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the dopaminergic tubero-hypophysial neurones in the maintenance of 'basal' melanocyte-stimulating hormone levels in the rat [proceedings].
    Penny RJ; Tilders FJ; Thody AJ
    J Endocrinol; 1979 Feb; 80(2):58P-59P. PubMed ID: 220369
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary studies of the characterization of dopaminergic receptors in the superior cervical ganglion of the calf].
    Trevisani A; Biondi C; Martini M; Perri V
    Boll Soc Ital Biol Sper; 1978 Nov; 54(21):2135-9. PubMed ID: 220992
    [No Abstract]   [Full Text] [Related]  

  • 9. [D-2 dopamine receptor and hormone release in the intermediate lobe of the pituitary gland].
    Munemura M
    Tanpakushitsu Kakusan Koso; 1986 Feb; 31(2):116-31. PubMed ID: 3014608
    [No Abstract]   [Full Text] [Related]  

  • 10. Supersensitivity of pituitary dopamine receptors involved in the inhibition of prolactin secretion.
    Annunziato L; Quattrone A; Schettini G; Di Renzo G
    Adv Biochem Psychopharmacol; 1980; 24():379-85. PubMed ID: 6105788
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor.
    Tsuruta K; Frey EA; Grewe CW; Cote TE; Eskay RL; Kebabian JW
    Nature; 1981 Jul; 292(5822):463-5. PubMed ID: 7254340
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions of ergot compounds with dopamine receptors and endocrine functions.
    Flückiger E
    J Neural Transm Suppl; 1983; 18():189-204. PubMed ID: 6576114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Absence of dopaminergic receptor sites identified with (H3)-spiroperidol in the intermediate lobe of the rabbit pituitary gland].
    Schimchowitsch S; Koch B; Stoeckel ME; Porte A
    C R Seances Acad Sci III; 1983; 297(6):323-6. PubMed ID: 6420002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of substituted benzamides in biochemical models of dopamine receptors.
    Kebabian JW; Tsuruta K; Cote TE; Grewe CW
    Adv Biochem Psychopharmacol; 1982; 35():17-49. PubMed ID: 6293277
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modifications of the intermediate lobe of the hypophysis after administration of metopirone].
    Calon N; Stahl A; de Lanversin A
    C R Assoc Anat; 1970 May; 147():164-70. PubMed ID: 4336622
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Stimulation of melanocyte-stimulating hormone release in vitro by cyclic AMP.
    Baker BI
    J Endocrinol; 1974 May; 61(2):LXXV. PubMed ID: 4365275
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence that dopamine is a neurotransmitter in the neurointermediate lobe of the hypophysis.
    Holzbauer M; Muscholl E; Racké K; Sharman DF
    Prog Brain Res; 1983; 60():357-64. PubMed ID: 6141589
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible role of cyclic AMP and prostaglandin E1 in the dopaminergic control of prolactin release.
    Ojeda SR; Harms PG; McCann SM
    Endocrinology; 1974 Dec; 95(6):1694-703. PubMed ID: 4373230
    [No Abstract]   [Full Text] [Related]  

  • 19. Ontogeny of basal and regulated proopiomelanocortin-derived peptide secretion from fetal and neonatal pituitary intermediate lobe cells: melanotrophs exhibit transient glucocorticoid responses during development.
    Lugo DI; Pintar JE
    Dev Biol; 1996 Jan; 173(1):110-8. PubMed ID: 8575613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of dopamine and the neurointermediate lobe of the pituitary in the regulation of prolactin secretion during late pregnancy in rats.
    Andrews ZB; Grattan DR
    J Neuroendocrinol; 2004 Oct; 16(10):859-65. PubMed ID: 15500546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.